The role of mTOR signaling in Alzheimer disease
Frontiers in Bioscience · 2012 · S4 (3) · 941-952
DOI: 10.2741/s310 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience, 2012. Verfasst von Salvatore Oddo. Beteiligte Einrichtung: Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. oddo@uthscsa.edu. Die Arbeit wurde bisher 211-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
The buildup of Abeta and tau is believed to directly cause or contribute to the progressive cognitive deficits characteristic of Alzheimer disease. However, the molecular pathways linking Abeta and tau accumulation to learning and memory deficits remain elusive. There is growing evidence that soluble forms of Abeta and tau can obstruct learning and memory by interfering with several signaling cascades. In this review, I will present data showing that the mammalian target of rapamycin (mTOR) may play a role in Abeta and tau induced neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. oddo@uthscsa.edu
Förderung
- NIA NIH HHS
Zitieren
APA
Oddo, S. (2012). The role of mTOR signaling in Alzheimer disease. Frontiers in Bioscience, S4(3), 941-952. https://doi.org/10.2741/s310
Vancouver
Oddo S. The role of mTOR signaling in Alzheimer disease. Frontiers in Bioscience. 2012;S4(3):941-952. doi:10.2741/s310
BibTeX
@article{Oddo2012,
author = {Oddo, Salvatore},
title = {The role of mTOR signaling in Alzheimer disease},
journal = {Frontiers in Bioscience},
year = {2012},
volume = {S4},
number = {3},
pages = {941--952},
doi = {10.2741/s310}
}
EUVIMED